Principal Financial Group Inc Supernus Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

  • $184 Billion
  • Q3 2025

A detailed history of Principal Financial Group Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 303,408 shares of SUPN stock, worth $13.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
303,408
Previous 305,631 0.73%
Holding current value
$13.7 Million
Previous $9.63 Million 50.51%
% of portfolio
0.01%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025
SELL
$31.45 - $47.79 $69,913 - $106,237
-2,223 Reduced 0.73%
303,408 $14.5 Million
Q2 2025

Aug 08, 2025
SELL
$30.29 - $33.43 $20,930 - $23,100
-691 Reduced 0.23%
305,631 $9.63 Million
Q1 2025

Apr 28, 2025
BUY
$31.17 - $40.0 $298,920 - $383,600
9,590 Added 3.23%
306,322 $10 Million
Q4 2024

Jan 31, 2025
BUY
$31.89 - $37.83 $9.46 Million - $11.2 Million
296,732 New
296,732 $10.7 Million
Q3 2024

Oct 31, 2024
BUY
$25.77 - $35.16 $375,365 - $512,140
14,566 Added 5.38%
285,411 $8.9 Million
Q2 2024

Jul 29, 2024
SELL
$25.99 - $33.85 $341,794 - $445,161
-13,151 Reduced 4.63%
270,845 $7.25 Million
Q1 2024

Apr 29, 2024
SELL
$27.11 - $35.17 $445,878 - $578,440
-16,447 Reduced 5.47%
283,996 $9.69 Million
Q4 2023

Feb 07, 2024
SELL
$22.72 - $29.68 $75,816 - $99,042
-3,337 Reduced 1.1%
300,443 $8.69 Million
Q3 2023

Nov 02, 2023
SELL
$27.57 - $32.91 $380,907 - $454,684
-13,816 Reduced 4.35%
303,780 $8.38 Million
Q2 2023

Aug 07, 2023
SELL
$29.91 - $38.73 $503,534 - $652,019
-16,835 Reduced 5.03%
317,596 $9.55 Million
Q1 2023

May 09, 2023
SELL
$34.93 - $42.03 $181,810 - $218,766
-5,205 Reduced 1.53%
334,431 $12.1 Million
Q4 2022

Feb 09, 2023
SELL
$31.09 - $37.88 $100,234 - $122,125
-3,224 Reduced 0.94%
339,636 $12.1 Million
Q3 2022

Nov 09, 2022
SELL
$28.79 - $35.41 $677,457 - $833,232
-23,531 Reduced 6.42%
342,860 $11.6 Million
Q2 2022

Aug 10, 2022
SELL
$25.33 - $34.25 $719,498 - $972,871
-28,405 Reduced 7.19%
366,391 $10.6 Million
Q1 2022

May 09, 2022
SELL
$28.51 - $32.9 $611,767 - $705,968
-21,458 Reduced 5.16%
394,796 $12.8 Million
Q4 2021

Feb 09, 2022
SELL
$26.37 - $34.22 $1 Million - $1.3 Million
-38,102 Reduced 8.39%
416,254 $12.1 Million
Q3 2021

Nov 09, 2021
BUY
$23.54 - $31.39 $17,490 - $23,322
743 Added 0.16%
454,356 $12.1 Million
Q2 2021

Aug 10, 2021
BUY
$26.72 - $33.19 $620,759 - $771,070
23,232 Added 5.4%
453,613 $14 Million
Q1 2021

May 10, 2021
BUY
$24.15 - $31.45 $154,535 - $201,248
6,399 Added 1.51%
430,381 $11.3 Million
Q4 2020

Feb 08, 2021
BUY
$17.7 - $25.81 $799,880 - $1.17 Million
45,191 Added 11.93%
423,982 $10.7 Million
Q3 2020

Nov 06, 2020
SELL
$20.2 - $25.05 $317,382 - $393,585
-15,712 Reduced 3.98%
378,791 $7.89 Million
Q2 2020

Aug 05, 2020
SELL
$17.09 - $24.89 $69,351 - $101,003
-4,058 Reduced 1.02%
394,503 $9.37 Million
Q1 2020

May 12, 2020
SELL
$14.45 - $24.69 $254,276 - $434,469
-17,597 Reduced 4.23%
398,561 $7.17 Million
Q4 2019

Feb 05, 2020
SELL
$19.93 - $29.13 $667,435 - $975,534
-33,489 Reduced 7.45%
416,158 $9.87 Million
Q3 2019

Nov 13, 2019
BUY
$25.47 - $33.37 $110,718 - $145,059
4,347 Added 0.98%
449,647 $12.4 Million
Q2 2019

Aug 12, 2019
SELL
$29.96 - $38.87 $508,720 - $660,012
-16,980 Reduced 3.67%
445,300 $14.7 Million
Q1 2019

May 10, 2019
SELL
$32.77 - $41.99 $78,680 - $100,817
-2,401 Reduced 0.52%
462,280 $16.2 Million
Q4 2018

Feb 14, 2019
BUY
$30.84 - $49.51 $372,670 - $598,278
12,084 Added 2.67%
464,681 $15.4 Million
Q3 2018

Nov 14, 2018
BUY
$42.7 - $56.55 $876,631 - $1.16 Million
20,530 Added 4.75%
452,597 $22.8 Million
Q2 2018

Aug 13, 2018
BUY
$44.1 - $59.85 $397,120 - $538,949
9,005 Added 2.13%
432,067 $0
Q1 2018

May 14, 2018
BUY
$37.15 - $46.9 $491,791 - $620,862
13,238 Added 3.23%
423,062 $19.4 Million
Q4 2017

Feb 13, 2018
BUY
$36.4 - $42.6 $110,983 - $129,887
3,049 Added 0.75%
409,824 $16.3 Million
Q3 2017

Nov 02, 2017
BUY
$36.75 - $49.65 $14.9 Million - $20.2 Million
406,775
406,775 $16.3 Million

Others Institutions Holding SUPN

# of Institutions
332
Shares Held
58.4M
Call Options Held
28.8K
Put Options Held
0
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.41B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email